Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
33 results
D2.138 - Type 3 cytokine - dependent E3 epithelial programming is driven by a novel transcriptional regulator that impacts airway barrier integrity in asthma
D2.142 - Longitudinal Airway Immune Responses to Respiratory Viruses in Asthmatic and Atopic Children
D2.146 - Neuropsychiatric events associated with montelukast in children: a systematic review
D2.135 - Preventive counseling regarding the risk factors for individuals with asthma or chronic obstructive pulmonary disease
D2.136 - Association Between Serum 25-Hydroxyvitamin D Levels and Asthma Severity in Preschool Children
D2.137 - Association of GLP-1 Receptor Agonists with Asthma Incidence among Patients with Obesity
D2.139 - Atypical Presentation of House Dust Mite–Induced Atopic Asthma in an Adolescent Girl: A Case Report from a Remote Region of Kyrgyzstan
D2.141 - Predictors of inpatient admission amongst children presenting with acute asthma exacerbation: influence of the patient’s prior clinical profile
D2.143 - Cypress pollen as a major aeroallergen in paediatric respiratory allergy: experience in Gaziantep, south-eastern Türkiye
D2.144 - Bronchial Inflammation and Lung Function in Children with Asthma and Allergic Rhinitis: The Contribution of FeNO and Spirometry
D2.145 - Parental Recognition and Consistency of Noisy Breathing Reports: Treatment and Symptom Associations
D2.148 - Exploring the Role of Bacterial Lysate OM-85 on Immune Mechanisms in Type 2-high Asthma
D3.157 - Clinical characteristics and associated factors of persistent asthma in preschool children with wheezing in a tropical region
D3.158 - Dupilumab Response in a Patient with Severe Asthma Refractory to Anti-IL5 Therapy: A Case Report
D3.165 - Phase 1 study of CDX-622, a bispecific antibody targeting TSLP and mast cells via stem cell factor
D3.153 - Add-on Dupilumab therapy significantly reduces severe asthma exacerbations and emergency visits in patients with severe persistent asthma requiring oral corticosteroids for maintenance therapy: our experience in Réunion Island
D3.154 - Trends in Bronchial Asthma Incidence in Crimea: Analysis from 2017-2024 with Age-Specific Insights
D3.155 - Th2–Th17 immune shift following dupilumab therapy
D3.156 - Pulmonary embolism in a young asthma patient
D3.159 - Early Bronchodilator Response in Asthma: When Is Testing Really Necessary?
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download